Obesity Drug Coverage Restrictions Impact Millions of Patients

Millions of patients have lost coverage for popular obesity drugs like Zepbound and Wegovy over the past year due to new restrictions, forcing many to seek alternative treatments.

22 Apr, 13:25 — 22 Apr, 13:25

Post Share

Sources

Showing 1 of 1 sources

NPRHigh127d ago

Restrictions on obesity drug coverage force patients to pivot

Twelve million people lost coverage for Zepbound over the last year. The same number of people lost coverage for Wegovy, according to an analysis by GoodRx, a drug discount website.

By Sydney Lupkin

Read full article →

PERSPECTA

PERSPECTA

Obesity Drug Coverage Restrictions Impact Millions of Patients

Sources

Restrictions on obesity drug coverage force patients to pivot

Related Stories

Trump Asserts Putin Will Not Attack NATO, Downplays CIA Chief’s Moscow Visit

Two Killed in Violent Attack at German High School Near Berlin

Zelensky Visits Moldova Amid Sustained Russian Drone and Missile Strikes on Ukraine

International Aid Mobilizes After Deadly Floods and Landslides Strike Nepal

PERSPECTA